Article
Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia.
BMC cancer - 21 Dec 2022
Liang Tianqi, Peng Zhiyong, Li Chunfu, Huang Junbin, Wang Huabin, Bu Chaoke, Li Jian, Zheng Yongzhi, Feng Xiaoqin, Li Huiping, Chen Chun
Abstract excerpt
BACKGROUND: Many cytogenetic changes and gene mutations are associated with acute myeloid leukemia (AML) survival outcomes. CD56 is related to poor prognosis when expressed in adult AML patients. However, the prognostic value of CD56 in children with AML has rarely been reported. In this research, we aimed to evaluate the prognostic value of CD56 in childhood AML. METHODS: The present retrospective study included...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
